News

Dr Adams is the co-founder of a number of successful diagnostic and pharmaceutical companies including Genprobe, Hybritech, Genta and Leucadia Technologies. Dr Adams is a senior executive of

“We are very excited to enter into this collaboration with Johnson & Johnson LLC to bring our advanced simulators into Russian hospitals, teaching facilities, and interventional clinics,” said

Meridian Bioscience has: Reported second quarter and six months net sales of $33.3 million and $67.6 million, respectively, decreases of 8% and 4% compared to the same periods

On an adjusted basis, excluding 2008 special items, Baxter’s first quarter net income increased 9% to $516 million from $474 million reported in the prior-year period, and earnings

Under the agreement, Amsino will be responsible for transportation and warehousing logistics, order management, customer service, quality assurance and bill collection. Robert McCullough, chief executive officer of CytoCore,

Carina Schmidt, CEO of Athera, said “We are very excited about the opportunities these agreements present to Athera. They will allow us to reach a large number of

Peregrine Pharmaceuticals, a biopharmaceutical company, has received a new US patent that is expected to strengthen the company’s intellectual property in the field of phospholipid-targeting agents for the

Orcrist Bio, a biotechnology company developing stem cell-mobilizing pharmaceuticals, has received approval from the European Competent Authority in Seville, Spain for its Phase I, open-label, single-ascending-dose, safety study

Millipore, a life science company, and Novozymes Biopharma, a provider of industrial bio-solutions, have launched CellPrime rAlbumin AF-G, a completely animal-free cell culture supplement designed for large scale